Developer docs
API playgroundTry for free, no card

Search company profiles

Intelligence Ventures

Full company profile

uuid00097dm

Namestring
Intelligence Ventures
Legal namestring
Intelligence Ventures
Company typeenum
Private
Founded yearint
2023
Descriptiontext

Intelligence Ventures is a pre-seed and seed-stage venture capital firm founded in 2023 and based in Bradenton, United States. The firm deploys checks of $25,000 to $50,000 into early-stage AI healthcare companies headquartered in the US and Canada, organized around four vertical theses: Biotech & Pharma Tools, Diagnostics, Medical Devices, and Healthcare SaaS. Its stated investment filter is proprietary data ownership, on the view that AI healthcare winners will be defined by defensible clinical, genomic, imaging, or operational datasets rather than model architecture alone.

The firm's central operating asset is a proprietary research dataset built from reviewing more than 630 AI healthcare startups at the earliest pipeline stage, packaged into an annual 60+ page State of AI Healthcare report covering 19 sections. This research function is the firm's primary differentiator against larger generalist healthcare and AI funds, and it is paired with a 350+ co-investor network and 20-30 inbound founder applications per week. The firm integrates TurboInnovate's AI-powered innovation intelligence platform (from OmniSync Incorporated) into deal screening and provides hands-on commercialization support to select portfolio companies. Its disclosed portfolio includes AGED Diagnostics (AI liver disease diagnostics), HEARTio (AI ECG analysis), Atapir (AI contactless vital sign monitoring), Directed Systems (AI cardiovascular copilot), and Medical Devices Corner (AI-enabled MRI-compatible robotic biopsies), with at least one disclosed co-investment in HEARTio's $4.25 million seed round closed March 2026.

Revenue is generated through standard emerging-manager venture fund economics — management fees on committed capital and carried interest on successful exits — though no fund size, AUM, or LP base is publicly disclosed. The firm is led by Doug Nissinoff (MS), Founder & Managing Partner, alongside Joey Bose (MS), operating with a 1-10 person team.

Short descriptiontext

Intelligence Ventures is a US-based pre-seed and seed venture capital firm founded in 2023 that deploys $25K-$50K checks into AI healthcare startups across four verticals in the US and Canada, differentiated by a proprietary research dataset covering 630+ companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTampa, United States
HQ citystring
Tampa
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital investing, AI healthcare startups, pre-seed seed funding, healthcare innovation, proprietary data moats
Industry2 codes
PRIMARYFSANAAAM
Accelerators & Incubators (Investor-Operated)
SECONDARYFSANACAA
Technology & Software Growth Equity
NAICS code1 code
  • Miscellaneous Financial Investment Activities523999
SIC code1 code
  • Investors, Nec6799
Product category
Healthcare Venture Capital
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Fund Management / Carried Interest
TypeSubscription Recurring
Description

As a venture capital firm, Intelligence Ventures generates returns through equity investments in early-stage AI healthcare companies. Revenue is derived from carried interest on successful exits and management fees.

intelligencevc.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Pre-Seed / Seed Investment
ModelOtherBilling cadenceMulti-year contract
Notes

Check sizes range from $25,000 to $50,000 for pre-seed and seed stage investments in AI healthcare companies.

intelligencevc.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Intelligence Ventures is a pre-seed and seed-stage venture capital firm that invests $25K–$50K checks in early-stage founders building AI-powered healthcare companies with proprietary data moats across the US and Canada. The firm operates a research-driven investing approach built on proprietary market intelligence covering 630+ startups across four verticals (Biotech & Pharma Tools, Diagnostics, Medical Devices, and Healthcare SaaS) and publishes the State of AI Healthcare annual report.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 630+ startups reviewed and counting
Product overview1 text field

Intelligence Ventures is a pre-seed and seed-stage venture capital firm (deploying $25K–$50K checks) focused on AI-powered healthcare companies with proprietary data moats in the US and Canada. The firm operates across four healthcare verticals: Biotech & Pharma Tools, Diagnostics, Medical Devices, and Healthcare SaaS. Intelligence Ventures's portfolio includes six AI healthcare companies: AGED Diagnostics (AI-powered liver disease blood tests), HEARTio (AI-driven ECG analysis for cardiac conditions), Atapir (AI-powered contactless vital signs monitoring via computer vision), Directed Systems (AI-powered cardiovascular copilot for surgical/critical care), and Medical Devices Corner (AI-enabled MRI-compatible robotic system for cancer biopsies). The firm differentiates through a research-driven approach and integrates TurboInnovate's AI market intelligence platform into its deal evaluation process.

Product and service3 records
1Intelligence Ventures Pre-Seed & Seed Fund
CategoryVenture Capital Fund
Description

Pre-seed and seed-stage venture capital fund deploying $25K–$50K check sizes into AI-powered healthcare startups across US and Canada. Targeted at early-stage founders building AI healthcare companies with proprietary data moats across four verticals: Biotech & Pharma Tools, Diagnostics, Medical Devices, and Healthcare SaaS.

2State of AI Healthcare Annual Report
CategoryResearch & Market Intelligence
Description

A 60+ page annual research publication built from the firm's proprietary dataset covering the earliest-stage AI healthcare pipeline in North America, including 19 sections mapping 4 healthcare verticals. Made available publicly to demonstrate the firm's research-driven thesis and to attract founders and LPs.

3TurboInnovate Market Intelligence Platform Integration
CategoryMarket Intelligence Platform
Description

An AI-powered innovation intelligence platform integrated into the fund's deal evaluation workflow to assess commercialization potential, competitive positioning, and funding likelihood for pre-seed and seed-stage AI healthcare companies. TurboInnovate's team also provides hands-on commercialization support to select portfolio companies.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1TurboInnovate
Strategic tierCoreTypeStrategic or Co-development Partner
Description

TurboInnovate, the AI-powered innovation intelligence platform from OmniSync Incorporated, partnered with Intelligence Ventures to integrate its market intelligence platform into the venture capital firm's deal evaluation workflow. Intelligence Ventures uses TurboInnovate to assess commercialization potential, competitive positioning, and funding likelihood for pre-seed and seed-stage AI healthcare companies. TurboInnovate's team also provides hands-on commercialization support to select portfolio companies.

prnewswire.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Early-stage venture firm with deep focus on the intersection of AI/technology and healthcare sciences. Highly comparable to Intelligence Ventures given shared thesis on proprietary data moats and active investing across frontier healthcare categories.

TypeDirect peer
Description

Venture fund founded by Bill Maris focused on healthcare, AI, and frontier technology. Directly comparable to Intelligence Ventures as an early-stage AI/healthcare thesis-driven investor with research-led sourcing.

TypeBroad incumbent
Description

Corporate venture arm of UnitedHealth/Optum investing in AI and digital health. Comparable in AI healthcare thesis but offers strategic payer-provider distribution unavailable to independent VCs like Intelligence Ventures.

TypeBroad incumbent
Description

Multi-stage venture firm with a dedicated Health Assurance and healthcare AI practice. Comparable as an active AI healthcare investor from seed through growth, though vastly larger and broader in mandate.

TypeDirect peer
Description

Early-stage venture firm exclusively focused on digital health and healthcare SaaS. Comparable to Intelligence Ventures' Healthcare SaaS vertical and overall pre-seed/seed healthcare investing focus.

TypeDirect peer
Description

Early-stage venture firm exclusively focused on digital health and healthcare technology. Directly comparable as a thesis-driven seed/Series A healthcare investor; similar size and stage focus to Intelligence Ventures.

TypeEmerging player
Description

Emerging venture firm investing in digital health, computational biology, and AI-driven life sciences. Comparable to Intelligence Ventures as a similarly-sized, thesis-led AI healthcare emerging manager at seed stage.

TypeDirect peer
Description

Venture firm focused on early-stage life sciences, diagnostics, and healthcare technology. Directly comparable to Intelligence Ventures' Diagnostics and Biotech & Pharma Tools verticals with deep technical founder relationships.

TypeBroad incumbent
Description

Major venture firm with dedicated bio/health fund investing across digital health, therapeutics, and AI healthcare. Comparable in target category but materially larger in AUM, stage range, and competitive deal access.

TypeBroad incumbent
Description

Large venture firm with significant dedicated AI and healthcare investing practice. Comparable as a thesis-driven investor in AI healthcare at seed and early stages, though much larger AUM and broader stage mandate.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment12 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Intelligence Ventures

Healthcare Venture Capitalintelligencevc.com

Intelligence Ventures is a US-based pre-seed and seed venture capital firm founded in 2023 that deploys $25K-$50K checks into AI healthcare startups across four verticals in the US and Canada, differentiated by a proprietary research dataset covering 630+ companies.

What Intelligence Ventures does

Intelligence Ventures is a pre-seed and seed-stage venture capital firm founded in 2023 and based in Bradenton, United States. The firm deploys checks of $25,000 to $50,000 into early-stage AI healthcare companies headquartered in the US and Canada, organized around four vertical theses: Biotech & Pharma Tools, Diagnostics, Medical Devices, and Healthcare SaaS. Its stated investment filter is proprietary data ownership, on the view that AI healthcare winners will be defined by defensible clinical, genomic, imaging, or operational datasets rather than model architecture alone.

The firm's central operating asset is a proprietary research dataset built from reviewing more than 630 AI healthcare startups at the earliest pipeline stage, packaged into an annual 60+ page State of AI Healthcare report covering 19 sections. This research function is the firm's primary differentiator against larger generalist healthcare and AI funds, and it is paired with a 350+ co-investor network and 20-30 inbound founder applications per week. The firm integrates TurboInnovate's AI-powered innovation intelligence platform (from OmniSync Incorporated) into deal screening and provides hands-on commercialization support to select portfolio companies. Its disclosed portfolio includes AGED Diagnostics (AI liver disease diagnostics), HEARTio (AI ECG analysis), Atapir (AI contactless vital sign monitoring), Directed Systems (AI cardiovascular copilot), and Medical Devices Corner (AI-enabled MRI-compatible robotic biopsies), with at least one disclosed co-investment in HEARTio's $4.25 million seed round closed March 2026.

Revenue is generated through standard emerging-manager venture fund economics — management fees on committed capital and carried interest on successful exits — though no fund size, AUM, or LP base is publicly disclosed. The firm is led by Doug Nissinoff (MS), Founder & Managing Partner, alongside Joey Bose (MS), operating with a 1-10 person team.

Intelligence Ventures firmographics

Firmographics
Name
Intelligence Ventures
Legal name
Intelligence Ventures
Website
https://intelligencevc.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
11–50 employees
Short description
Intelligence Ventures is a US-based pre-seed and seed venture capital firm founded in 2023 that deploys $25K-$50K checks into AI healthcare startups across four verticals in the US and Canada, differentiated by a proprietary research dataset covering 630+ companies.
Ownership category
akta.pro rank

Intelligence Ventures industry classification

Industry
Product category
Healthcare Venture Capital
NAICS
Miscellaneous Financial Investment Activities (523999)
SIC
Investors, Nec (6799)
akta.pro industry
PRIMARYFSANAAAM
Accelerators & Incubators (Investor-Operated)
SECONDARYFSANACAA
Technology & Software Growth Equity

Keywords

  • Venture capital investing
  • AI healthcare startups
  • Pre-seed seed funding
  • Healthcare innovation
  • Proprietary data moats

Where Intelligence Ventures is headquartered

Location

Headquarters

HQ city
Tampa
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Intelligence Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Fund Management / Carried Interest: As a venture capital firm, Intelligence Ventures generates returns through equity investments in early-stage AI healthcare companies. Revenue is derived from carried interest on successful exits and management fees.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractPre-Seed / Seed Investment

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Intelligence Ventures product offering

Product offering

Core offering

Intelligence Ventures is a pre-seed and seed-stage venture capital firm that invests $25K–$50K checks in early-stage founders building AI-powered healthcare companies with proprietary data moats across the US and Canada. The firm operates a research-driven investing approach built on proprietary market intelligence covering 630+ startups across four verticals (Biotech & Pharma Tools, Diagnostics, Medical Devices, and Healthcare SaaS) and publishes the State of AI Healthcare annual report.

Product overview

Intelligence Ventures is a pre-seed and seed-stage venture capital firm (deploying $25K–$50K checks) focused on AI-powered healthcare companies with proprietary data moats in the US and Canada. The firm operates across four healthcare verticals: Biotech & Pharma Tools, Diagnostics, Medical Devices, and Healthcare SaaS. Intelligence Ventures's portfolio includes six AI healthcare companies: AGED Diagnostics (AI-powered liver disease blood tests), HEARTio (AI-driven ECG analysis for cardiac conditions), Atapir (AI-powered contactless vital signs monitoring via computer vision), Directed Systems (AI-powered cardiovascular copilot for surgical/critical care), and Medical Devices Corner (AI-enabled MRI-compatible robotic system for cancer biopsies). The firm differentiates through a research-driven approach and integrates TurboInnovate's AI market intelligence platform into its deal evaluation process.

Differentiator

Problem solved

Functional benefit

Products and services

  • Intelligence Ventures Pre-Seed & Seed Fund Pre-seed and seed-stage venture capital fund deploying $25K–$50K check sizes into AI-powered healthcare startups across US and Canada. Targeted at early-stage founders building AI healthcare companies with proprietary data moats across four verticals: Biotech & Pharma Tools, Diagnostics, Medical Devices, and Healthcare SaaS.
  • State of AI Healthcare Annual Report A 60+ page annual research publication built from the firm's proprietary dataset covering the earliest-stage AI healthcare pipeline in North America, including 19 sections mapping 4 healthcare verticals. Made available publicly to demonstrate the firm's research-driven thesis and to attract founders and LPs.
  • TurboInnovate Market Intelligence Platform Integration An AI-powered innovation intelligence platform integrated into the fund's deal evaluation workflow to assess commercialization potential, competitive positioning, and funding likelihood for pre-seed and seed-stage AI healthcare companies. TurboInnovate's team also provides hands-on commercialization support to select portfolio companies.

Quantifiable outcome

  • 630+ startups reviewed and counting

Companies that use Intelligence Ventures

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles2 records

Intelligence Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Intelligence Ventures partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • TurboInnovatecoreStrategic or Co-development PartnerTurboInnovate, the AI-powered innovation intelligence platform from OmniSync Incorporated, partnered with Intelligence Ventures to integrate its market intelligence platform into the venture capital firm's deal evaluation workflow. Intelligence Ventures uses TurboInnovate to assess commercialization potential, competitive positioning, and funding likelihood for pre-seed and seed-stage AI healthcare companies. TurboInnovate's team also provides hands-on commercialization support to select portfolio companies.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Intelligence Ventures competitors and assessment

Company assessment

Direct peers

  • Lux Capital: Early-stage venture firm with deep focus on the intersection of AI/technology and healthcare sciences. Highly comparable to Intelligence Ventures given shared thesis on proprietary data moats and active investing across frontier healthcare categories.
  • Section 32: Venture fund founded by Bill Maris focused on healthcare, AI, and frontier technology. Directly comparable to Intelligence Ventures as an early-stage AI/healthcare thesis-driven investor with research-led sourcing.
  • Define Ventures: Early-stage venture firm exclusively focused on digital health and healthcare SaaS. Comparable to Intelligence Ventures' Healthcare SaaS vertical and overall pre-seed/seed healthcare investing focus.
  • Flare Capital Partners: Early-stage venture firm exclusively focused on digital health and healthcare technology. Directly comparable as a thesis-driven seed/Series A healthcare investor; similar size and stage focus to Intelligence Ventures.
  • ARCH Venture Partners: Venture firm focused on early-stage life sciences, diagnostics, and healthcare technology. Directly comparable to Intelligence Ventures' Diagnostics and Biotech & Pharma Tools verticals with deep technical founder relationships.

Broad incumbents

  • Optum Ventures: Corporate venture arm of UnitedHealth/Optum investing in AI and digital health. Comparable in AI healthcare thesis but offers strategic payer-provider distribution unavailable to independent VCs like Intelligence Ventures.
  • General Catalyst: Multi-stage venture firm with a dedicated Health Assurance and healthcare AI practice. Comparable as an active AI healthcare investor from seed through growth, though vastly larger and broader in mandate.
  • Andreessen Horowitz (a16z Bio + Health): Major venture firm with dedicated bio/health fund investing across digital health, therapeutics, and AI healthcare. Comparable in target category but materially larger in AUM, stage range, and competitive deal access.
  • Khosla Ventures: Large venture firm with significant dedicated AI and healthcare investing practice. Comparable as a thesis-driven investor in AI healthcare at seed and early stages, though much larger AUM and broader stage mandate.

Emerging players

  • Civilization Ventures: Emerging venture firm investing in digital health, computational biology, and AI-driven life sciences. Comparable to Intelligence Ventures as a similarly-sized, thesis-led AI healthcare emerging manager at seed stage.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Intelligence Ventures social profiles

Digital presence

Intelligence Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Intelligence Ventures leadership team

Management profile

Number of profiles

Profiles2 records

Intelligence Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Intelligence Ventures M&A and investment

M&A and investment

M&A

Investments12 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Intelligence Ventures

What does Intelligence Ventures do?

Intelligence Ventures is a pre-seed and seed-stage venture capital firm that invests $25K–$50K checks in early-stage founders building AI-powered healthcare companies with proprietary data moats across the US and Canada. The firm operates a research-driven investing approach built on proprietary market intelligence covering 630+ startups across four verticals (Biotech & Pharma Tools, Diagnostics, Medical Devices, and Healthcare SaaS) and publishes the State of AI Healthcare annual report.

Is Intelligence Ventures a public or private company?

Intelligence Ventures is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Intelligence Ventures founded?

Intelligence Ventures was founded in 2023. It employs 11 to 50 people.

Where is Intelligence Ventures based?

Intelligence Ventures is headquartered in Tampa, United States, in the North America region.

How does Intelligence Ventures make money?

One revenue line is on record: fund Management / Carried Interest.

Who are Intelligence Ventures's main competitors?

Direct peers on record are Lux Capital, Section 32, Define Ventures, Flare Capital Partners and ARCH Venture Partners. Broad incumbents are Optum Ventures, General Catalyst, Andreessen Horowitz (a16z Bio + Health) and Khosla Ventures. Civilization Ventures is listed as an emerging player.

Does Intelligence Ventures have an API?

No public API is recorded for Intelligence Ventures.

What industry is Intelligence Ventures in?

Intelligence Ventures's product category is Healthcare Venture Capital. Its primary akta.pro industry code is FSANAAAM, Accelerators & Incubators (Investor-Operated), with a secondary code of FSANACAA, Technology & Software Growth Equity. Its NAICS code is 523999 and its SIC code is 6799.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
StpetecatalystIntelligence Ventures to launch accelerator programIntelligence Ventures, a Lakewood Ranch-based venture capital firm focused on AI-powered healthcare startups, has launched an accelerator program targeting 10 startups for its first cohort beginning in September. Each enrolled startup will receive a $25,000 investment, with top performers eligible for an additional $25,000 following a demo day in New York City. The 10-week program combines in-person sessions in the Tampa Bay area with online programming and is open to companies from the U.S. and Canada.EIN PresswireShepherd Ventures III portfolio company HEARTio Closes $4.25 Million Financing for AI-based Warning of Heart AttacksHEARTio closed $4.25 million in seed financing with Shepherd Ventures III and other investors. The funds will support a pivotal study for FDA clearance of its ECGio AI platform, which detects coronary occlusion from ECGs. Shepherd Ventures III plans to lead a scaling round after clearance.PR NewswireTurboInnovate Partners with Intelligence Ventures to Bring AI-Powered Predictions to Investment DiligenceTurboInnovate, the AI-powered innovation intelligence platform from OmniSync Incorporated, announced a strategic partnership with Intelligence Ventures to integrate its market intelligence platform into the venture capital firm's deal evaluation workflow. Under the agreement, Intelligence Ventures will use TurboInnovate to assess commercialization potential, competitive positioning, and funding likelihood for pre-seed and seed-stage AI healthcare companies, with TurboInnovate's team also providing hands-on commercialization support to select portfolio companies. The CEO of OmniSync stated that the platform is expected to become standard for serious deep tech and life science investors within the next 18 months.LinkedInUpfront Diagnostics raises $4.3M for stroke testIntelligence Ventures announced a $4.3M investment in AGED Diagnostics, a company developing a noninvasive diagnostic test for stroke. The post also references a separate investment in NASH diagnostics, but the primary focus is the stroke test funding.